Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GLP-1 Booster
- Development stage
- Preclinical
- Lead developer
- Alpine Biotech LLC
- Modality
- Small Molecules
01
Overview
GLP-1 Booster (GB) is a dietary supplement composed of various plant extracts, including Green tea leaf, Gardeniae fructus, Turmeric root, Black pepper, Fenugreek seed, Ginseng root, and White kidney bean extracts. It is designed to stimulate the endogenous production of Glucagon-like Peptide-1 (GLP-1), improve its activity, and enhance the body's response to GLP-1. This mechanism aims to promote insulin release, control blood glucose levels, suppress appetite, and facilitate body fat loss and weight management. Clinical studies are underway to assess its efficacy and safety in healthy volunteers and overweight adults.
02
Targets
GLP-1 (Glucagon-like peptide-1)
Beyond the preview
Go deeper on GLP-1 Booster.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GLP-1 Booster.